{'fraction_non_alphanumeric': 0.029891304347826088, 'fraction_numerical': 0.019021739130434784, 'mean_word_length': 5.207865168539326, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

affecting 20-30% of the general population, and recent studies indicate that fatty liver is an emerging problem in the Asia-Pacific region. 3 A comprehensive review of available data reveals that the overall prevalence of NAFLD in the Asia-Pacific region is broadly similar to that in North America, affecting between 12% and 24% of community subgroups. 4,5 The prevalence varies by age, gender, ethnicity, and locality (urban versus rural), as well as with criteria used for disease definition. 5 There is strong evidence that the prevalence of NAFLD in this region has increased substantially during the last 15 years in parallel with regional trends in over- nutrition (decreased physical activity with disproportionate food intake), central and overall obesity, type 2 diabetes mellitus (T2DM), and the metabolic syndrome. 6-8 Present trends in the obesity and diabetes pandemic indicate that a further increase in NAFLD prevalence is likely in the immediate future. 9,10